REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSunrise Res Regulatory News (SRES)

Share Price Information for Sunrise Res (SRES)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0475
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.005 (11.111%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.0475
SRES Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

21 May 2018 10:30

RNS Number : 7161O
Sunrise Resources Plc
21 May 2018
 
21 May 2018 SUNRISE RESOURCES PLC

(the "Company")

 

HALF-YEARLY REPORT

 

Sunrise Resources plc, the AIM-traded company focusing on the development of its CS Pozzolan-Perlite Project in Nevada, USA, announces its unaudited interim results for the six months ended 31 March 2018.

 

Operational Highlights

 

CS Pozzolan-Perlite Project (Nevada, USA; 100% owned)

 

• Targeting first production in first half of 2019.

 

• Phase 2 drill programme completed to better define the mineral zones of commercial interest and assist in the preparation of mine plans.

 

Ø Thick zones of pozzolan intersected from bedrock surface (immediately beneath shallow colluvium) in Main Zone and Tuff Zone and in step out holes in Main Zone and Northeast Zone.

 

Ø Thick perlite intersections also encountered in Main Zone.

 

• Positive testwork continuing on Pozzolan and Perlite:

 

Ø Results on three composite samples of pozzolan show that the product mitigates the negative impact of "concrete cancer" and places it amongst the best natural pozzolans available on the market.

 

Ø Perlite testing now focused on application specific testing for marketing.

 

• Permitting work well underway. Lead agency, the US Bureau of Land Management, has appointed interdisciplinary project permitting team for the project.

 

Junction Copper-Silver-Gold Project (Nevada, USA; Share and Royalty interest)

 

• 2018 surface exploration at Junction underway with gravity survey already completed.

 

• Large high-contrast gravity anomaly at Denio Summit confirms the down dip potential of copper-silver veins, all in the Sunrise Area of Interest.

 

• Further exploration planned for this Spring at Junction to include induced polarisation geophysical survey and airborne magnetic and radiometric survey.

 

Bakers Gold Project (Western Australia; 100% owned, for sale or joint venture)

 

• Mapping and chip sampling of gold bearing quartz-stockwork veins in Dicky Lee open pit; gold values to 32.1 grammes/tonne gold ("g/t Au"), averaging 1.7 g/t Au.

 

• Infill soil sampling at DRL4 target confirms 500m long gold-in-soil anomaly, increases tenor and enhances definition of drill target.

 

Results Summary

 

Loss

 

Group loss for the six-month period of £174,517 (six months to 31 March 2017: £162,869) comprising:

 

 

 

· Interest income of £55; less

· Administration costs of £150,760; and

· Expensed exploration costs totalling £5,786; and

· Impairment of deferred exploration costs of £17,433 and

· Loss in value of accrued income on disposal of exploration asset of £593.

 

Funding

 

· On 6 December 2017 a total of £500,000 (before expenses) was raised through the issue of 333,333,333 new ordinary shares by way of a placing at a price of 0.15p.

 

· On 31 October 2017, 6,802,353 new ordinary shares were issued at a price of 0.17p to the three directors in settlement of directors' fees totalling £11,564.

 

About Natural Pozzolan

 

Pozzolan is a cementitious material that can partially replace ordinary Portland cement in cement and concrete mixes in amounts up to 35%. Natural pozzolans, therefore, have strong "green" credentials as the production of Portland cement is responsible for 5% of the global man-made carbon dioxide emissions with nearly one tonne of carbon dioxide (CO2) generated for each tonne of cement produced. Natural pozzolans can also improve the strength and chemical resistance of concrete. Natural pozzolans can also replace industrial by-product pozzolans in cement such as coal fly ash. The availability and quality of fly ash is under threat as coal-fired power stations are phased out in favour of natural gas plants and fly ash quality becomes more variable due to increased emission control legislation.

 

About Perlite

 

Perlite is a glassy raw material which, when heated in a furnace, pops like popcorn and expands by up to 20 times in volume into a white or pale coloured, low density material. Expanded perlite is used in various industrial and household applications such as insulation, paint texturing, building materials, filter aids, insulating industrial cryogenic storage vessels and as a potting medium in gardening and horticulture to aid water retention and aeration of the soil. Some perlites can also be used as a natural pozzolan.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

 

Further information

 

Sunrise Resources plc

Patrick Cheetham, Executive Chairman

Tel:

+44 (0)1625 838 884

 

 

 

Northland Capital Partners Limited

Nominated Adviser & Broker

Matthew Johnson/Edward Hutton/

Jamie Spotswood

John Howes/Rob Rees

Tel:

+44 (0)20 3861 6625

 

 

 

CAUTIONARY NOTICE

The news release may contain certain statements and expressions of belief, expectation or opinion which are forward looking statements, and which relate, inter alia, to the Company's proposed strategy, plans and objectives or to the expectations or intentions of the Company's directors. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond the control of the Company that could cause the actual performance or achievements of the Company to be materially different from such forward-looking statements. Accordingly, you should not rely on any forward-looking statements and save as required by the AIM Rules for Companies or by law, the Company does not accept any obligation to disseminate any updates or revisions to such forward-looking statements.

 

 

Chairman's Statement

 

I am pleased to be reporting on progress during the six-month financial reporting period ended 31 March 2018.

 

Since reporting developments up to mid-December 2017 in our last Annual Report, we have made good progress towards the development of our CS Pozzolan-Perlite Project in Nevada, USA. A second drill programme in January 2018 delivered thick and open-ended intersections of pozzolan in the Main and Tuff Zones from bedrock surface and in step-out holes in both the Main Zone and Northeast Zone and demonstrated potential to add substantially to the known pozzolan deposits in the Tuff and Main Zones. We are now very confident that the Main and Northeast Zones are part of one continuous zone with a very large open-pit tonnage potential.

 

Our testwork programmes, which include Phase 2 drill samples, are continuing and a particularly important result has been the confirmation that the Company's CS Pozzolan can mitigate the effects of reactive aggregates in concrete mixes which can otherwise lead to deleterious expansion and concrete cancer. The results place it amongst the best commercially available pozzolans and will assist the Company in positioning its products in the market.

 

We are pushing ahead with mine planning and permitting, and season sensitive environmental baseline studies have been completed or are in progress. We are also starting to see the results of our market development work and a significant step forward was the recent signing of an MOU for an offtake agreement and commercial testing with a major buyer and processor of raw perlite. This could account for a significant proportion of the production tonnage required to justify development of the Company's perlite deposits. Whilst non-binding, it does establish a working relationship and demonstrates that the perlite deposits at our CS and NewPerl Projects are creating significant interest amongst consumers of raw perlite. The market for horticultural grades of perlite is particularly strong with market growth being driven in part by the growth in the legal cannabis market in parts of the USA.

 

The value in our broader portfolio of mineral projects and interests should not be overlooked. We continue to follow our small investment in Block Energy plc (formerly Goldcrest Resources Plc) which has made good progress in transforming itself to a Georgia based oil and gas producer and which is planning to list on AIM. Our holding in Canadian TSX listed VR Resources Ltd also looks poised for growth as it continues its exploration of the Junction Copper-Silver-Gold Project, where we retain contingent rights to additional shares and a royalty interest. This is developing into an exciting exploration project. A compelling gravity anomaly has now been discovered with a very strong spatial association to the high grade surface copper-silver showings at the Denio Summit target showing potential for significant downdip continuation of the sulphide veins and a sulphide bearing intrusive source.

 

We have carried out a small, low cost exploration programme at our Baker's Gold project in Australia generating new and positive exploration results that will enhance the value and marketability of the Baker's Gold project as we continue our divestment programme of non-core assets.

 

The Company reports a loss for the six-month period as expected and this includes a small write down of expenditure on our Austin Ash Project where the Board has determined that future exploration is unlikely due to the lower quality of the pozzolan at that locality compared to our CS Project. 

 

We are continuing to push hard in developing the CS Project with the ambition to deliver first production by the end of the first half of 2019 and we look forward to reporting further progress on a regular basis.

 

 

 

 

Patrick Cheetham

Executive Chairman

 

21 May 2018

 

 

 

Consolidated Income Statement

for the six months to 31 March 2018

 

 

 

Six months

to 31 March

2018

Unaudited

 

 

Six months

to 31 March

2017

Unaudited

 

 

 

Twelve months to

30 September

2017

Audited

 

£

 

£

 

£

 

 

 

 

 

 

Pre-licence and other exploration costs

5,786

 

14,851

 

21,161

 

 

 

 

 

 

Impairment of deferred exploration cost

17,433

 

-

 

3,077

 

 

 

 

 

 

Administrative expenses

150,760

 

134,741

 

276,568

 

 

 

 

 

 

Operating loss

(173,979)

 

(149,592)

 

(300,806)

 

 

 

 

 

 

Impairment of available for sale investment

-

 

(13,338)

 

(13,338)

 

 

 

 

 

 

(Loss)/gain on disposal of exploration asset

(593)

 

-

 

3,028

 

 

 

 

 

 

Interest

55

 

61

 

70

 

 

 

 

 

 

 

 

 

 

 

 

Loss before income tax

(174,517)

 

(162,869)

 

(311,046)

 

 

 

 

 

 

Income tax

 

-

 

-

 

-

 

 

 

 

 

 

Loss for the period attributable to equity

holders of the parent

 

(174,517)

 

 

(162,869)

 

 

(311,046)

 

 

 

 

 

 

Loss per share - basic and fully diluted (pence) (Note 2)

 

(0.009)

 

 

(0.013)

 

 

(0.022)

 

 

 

Consolidated Statement of Comprehensive Income

for the six months to 31 March 2018

 

 

 

 

 

 

Six months

to 31 March

2018

Unaudited

 

 

Six months

to 31 March

2017

Unaudited

 

 

 

Twelve months

to 30 September

2017

Audited

 

£

 

£

 

£

 

 

 

 

 

 

Loss for the period

(174,517)

 

(162,869)

 

(311,046)

 

 

 

 

 

 

Items that could be reclassified subsequently to the income statement:

 

 

 

 

 

 

 

 

 

 

 

Fair value movement on available for sale investment

 

(586)

 

 

1,676

 

 

12,471

 

Foreign exchange translation differences on foreign currency net investments in subsidiaries

 

 

(77,165)

 

 

 

43,477

 

 

 

(35,169)

 

 

 

 

 

 

 Total comprehensive loss for the period attributable to equity holders of the parent

 

 

(252,268)

 

 

 

(117,716)

 

 

 

(333,744)

 

   Company Registration Number: 05363956

Consolidated Statement of Financial Position

as at 31 March 2018

 

 

 

As at

31 March

2018

Unaudited

 

 

As at

31 March

2017

Unaudited

 

 

 

As at

30 September

2017

Audited

 

£

 

£

 

£

 

 

 

 

 

 

Non-current assets

 

 

 

 

 

Intangible assets

1,456,639

 

1,183,369

 

1,302,404

Available for sale investment

29,539

 

11,662

 

30,478

 

 

 

 

 

 

 

1,486,178

 

1,195,031

 

1,332,882

 

 

 

 

 

 

Current assets

 

 

 

 

 

Receivables

55,926

 

40,486

 

62,142

Cash and cash equivalents

320,712

 

287,982

 

234,181

 

 

 

 

 

 

 

376,638

 

328,468

 

296,323

 

 

 

 

 

 

Current liabilities

Trade and other payables

 

(123,949)

 

 

(108,205)

 

 

(112,901)

 

 

 

 

 

 

Net current assets/(liabilities)

252,689

 

220,263

 

183,422

 

 

 

 

 

 

Net assets

1,738,867

 

1,415,294

 

1,516,304

 

 

 

 

 

 

Equity

 

 

 

 

 

Called up share capital

2,144,151

 

1,464,710

 

1,804,016

Share premium account

4,926,718

 

4,815,734

 

4,792,790

Share warrant reserve

67,230

 

88,572

 

89,248

Available for sale investment reserve

10,209

 

-

 

10,795

Foreign currency reserve

(57,416)

 

98,395

 

19,749

Accumulated losses

(5,352,025)

 

(5,052,117)

 

(5,200,294)

 

 

 

 

 

 

Equity attributable to owners of the parent

1,738,867

 

1,415,294

 

1,516,304

 

 

 

 

 

Consolidated Statement of Changes in Equity

 

 

 

 

Share

capital

 

Share

premium

account

 

Share

warrant reserve

 

Available

for sale

 reserve

 

Foreign

currency

reserve

 

 

 Accumulated

losses

 

 

 

Total

 

£

£

£

£

£

£

£

At 30 September 2016

1,119,910

4,818,998

119,899

(1,676)

54,918

(4,921,406)

1,190,643

Loss for the period

-

-

-

-

-

(149,531)

(149,531)

Change in fair value

-

-

-

(11,662)

-

-

(11,662)

Transfer of impairment to income statement

-

-

-

13,338

-

(13,338)

-

Exchange differences

-

-

-

-

43,477

-

43,477

Total comprehensive

 

 

 

 

 

 

 

loss for the period

-

-

-

1,676

43,477

(162,869)

(117,716)

Share issue

344,800

(3,264)

-

-

-

-

341,536

Share based payments expense

-

-

831

-

-

-

831

Transfer of expired warrants

-

-

(32,158)

-

-

32,158

-

At 31 March 2017

1,464,710

4,815,734

88,572

-

98,395

(5,052,117)

1,415,294

Loss for the period

-

-

-

-

-

(148,177)

(148,177)

Change in fair value

-

-

-

10,795

-

-

10,795

Exchange differences

-

-

-

-

(78,646)

-

(78,646)

Total comprehensive

 

 

 

-

 

 

 

loss for the period

-

-

-

10,795

(78,646)

(148,177)

(216,028)

Share issue

339,306

(22,944)

-

-

-

-

316,362

Share based payments expense

-

-

676

-

-

-

676

At 30 September 2017

1,804,016

4,792,790

89,248

10,795

19,749

(5,200,294)

1,516,304

Loss for the period

-

-

-

-

-

(174,517)

(174,517)

Change in fair value

-

-

-

(586)

-

-

(586)

Exchange differences

-

-

-

-

(77,165)

-

(77,165)

Total comprehensive

 

 

 

 

 

 

 

loss for the period

-

-

-

(586)

(77,165)

(174,517)

(252,268)

Share issue

340,135

133,928

-

-

-

-

474,063

Share based payments expense

-

-

768

-

-

-

768

Transfer of expired warrants

-

-

(22,786)

-

-

22,786

-

At 31 March 2018

2,144,151

4,926,718

67,230

10,209

(57,416)

(5,352,025)

1,738,867

Consolidated Statement of Cash Flows

for the six months to 31 March 2018

 

 

Six months

to 31 March

2018

Unaudited

 

Six months

to 31 March

2017

Unaudited

 

 

Twelve months

to 30 September

2017

Audited

 

£

 

£

 

£

Operating activity

 

 

 

 

 

 

Operating Loss

(173,979)

 

(149,592)

 

(300,806)

Share based payment charge

768

 

831

 

1,507

Shares issued in lieu of net wages

11,564

 

-

 

15,736

Impairment charge - exploration

17,433

 

-

 

3,077

Accrued income

(939)

 

-

 

7,854

(Increase)/decrease in receivables

6,216

 

3,120

 

(18,536)

Increase/(decrease) in trade and other payables

11,048

 

(63,921)

 

(59,225)

 

 

 

 

 

 

Net cash outflow from operating activity

(127,889)

 

(209,562)

 

(350,393)

 

 

 

 

 

 

Investing activity

 

 

 

 

 

 

 

 

 

 

 

Interest received

55

 

61

 

70

Disposal of development asset

-

 

-

 

7,467

Development expenditures

(238,658)

 

(68,707)

 

(273,814)

 

 

 

 

 

 

Net cash outflow from investing activity

(238,603)

 

(68,646)

 

(266,277)

 

 

 

 

 

 

Financing activity

 

 

 

 

 

 

 

 

 

 

 

Issue of share capital (net of expenses)

462,500

 

341,536

 

642,162

 

 

 

 

 

 

Net cash inflow from financing activity

462,500

 

341,536

 

642,162

 

 

 

 

 

 

Net increase/(decrease) in cash and cash equivalents

96,008

 

63,328

 

25,492

 

 

 

 

 

 

Cash and cash equivalents at start of period

234,181

 

223,268

 

223,268

Exchange differences

(9,477)

 

1,386

 

(14,579)

 

 

 

 

 

 

Cash and cash equivalents at end of period

320,712

 

287,982

 

234,181

 

Notes to the Interim Statement

 

1. Basis of preparation

 

The consolidated interim financial information has been prepared in accordance with the accounting policies that are expected to be adopted in the Group's full financial statements for the year ending 30 September 2018 which are not expected to be significantly different to those set out in Note 1 of the Group's audited financial statements for the year ended 30 September 2017. These are based on the recognition and measurement principles of IFRS in issue as adopted by the European Union (EU) or that are expected to be adopted and effective at 30 September 2018. The financial information has not been prepared (and is not required to be prepared) in accordance with IAS 34. The accounting policies have been applied consistently throughout the Group for the purposes of preparation of this financial information.

 

The financial information in this statement relating to the six months ended 31 March 2018 and the six months ended 31 March 2017 has neither been audited nor reviewed by the Auditors pursuant to guidance issued by the Auditing Practices Board. The financial information presented for the year ended 30 September 2017 does not constitute the full statutory accounts for that period. The Annual Report and Financial Statements for the year ended 30 September 2017 have been filed with the Registrar of Companies. The Independent Auditor's Report on the Annual Report and Financial Statements for the year ended 30 September 2017 was unqualified, although did draw attention to matters by way of emphasis in relation to going concern, and did not contain a statement under 498(2) or 498(3) of the Companies Act 2006.

 

The directors prepare annual budgets and cash flow projections for a 15 month period. These projections include the proceeds of future fundraising necessary within the period to meet the Company's and Group's planned discretionary project expenditures and to maintain the Company and Group as a going concern. Although the Company has been successful in raising finance in the past, there is no assurance that it will obtain adequate finance in the future. This represents a material uncertainty related to events or conditions which may cast significant doubt on the entity's ability to continue as a going concern and, therefore, that it may be unable to realise its assets and discharge its liabilities in the normal course of business. However, the directors have a reasonable expectation that they will secure additional funding when required to continue meeting corporate overheads and exploration costs for the foreseeable future and therefore believe that the going concern basis is appropriate for the preparation of the financial statements.

 

 

2. Loss per share

 

Loss per share has been calculated on the attributable loss for the period and the weighted average number of shares in issue during the period.

 

 

Six months

 to 31 March

2018

Unaudited

 

 

Six months

to 31 March

2017

Unaudited

 

 

Twelve months

to 30 September

2017

Audited

 

 

 

 

 

Loss for the period (£)

(174,517)

(162,869)

(311,046)

 

Weighted average shares in issue (No.)

 

2,020,282,088

 

1,190,845,858

 

1,418,016,156

 

 

 

 

Basic and diluted loss per share (pence)

(0.009)

(0.013)

(0.022)

 

The loss attributable to ordinary shareholders and weighted average number of shares for the purpose of calculating the diluted earnings per share are identical to those used for the basic earnings per share. This is because the exercise of share warrants would have the effect of reducing the loss per share and is therefore not dilutive under the terms of IAS33.

 

 

 

 

 

3. Share capital

 

During the six months to 31 March 2018 the following share issues took place:

 

An issue of 6,802,353 Ordinary Shares at 0.17p per share to three directors, for a total consideration of £11,564, in satisfaction of directors' fees (31 October 2017).

 

An issue of 333,333,333 Ordinary Shares at 0.15p per share, by way of placing, for a total consideration of £462,500 net of expenses (6 December 2017).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR SEISUFFASEFI
Date   Source Headline
2nd Apr 20247:00 amRNSSALE OF DIATOMITE CLAIMS
28th Mar 20247:00 amRNSTotal Voting Rights
7th Mar 202411:20 amRNSDIRECTOR DEALING
5th Mar 20247:00 amRNSIssue of Shares following Conversion & TVR
29th Feb 202410:11 amRNSTotal Voting Rights
23rd Feb 202412:27 pmRNSDIRECTOR DEALING, ISSUE OF EQUITY & TVR
23rd Feb 202411:35 amRNSVoting at AGM
22nd Feb 202412:32 pmRNSResult of AGM
26th Jan 202410:00 amRNSANNUAL REPORT AND NOTICE OF 2024 AGM
24th Jan 20247:00 amRNSFinal Results
18th Jan 20247:00 amRNSPioche Sepiolite Project
27th Dec 202310:31 amRNSPioche Sepiolite Project
4th Dec 20231:55 pmRNSGarfield Royalty Interest
1st Dec 20237:00 amRNSInvestor Presentation
22nd Nov 20239:51 amRNSResult of Meeting
7th Nov 20237:00 amRNSProposed Sub-Division of Share Capital
31st Oct 20237:00 amRNSReese Ridge Zinc-Lead-Silver (-Gallium) Project
27th Sep 20237:00 amRNSPioche Project Update
15th Sep 20237:00 amRNSMarket Study and Pozzolan Project Update
31st Aug 20236:09 pmRNSTotal Voting Rights
11th Aug 202312:51 pmRNSIssue of Shares following Conversion & TVR
11th Aug 202312:45 pmRNSISSUE OF WARRANTS
3rd Aug 20234:20 pmRNSHolding(s) in Company
25th Jul 20237:00 amRNSPioche Resource Drilling Programme in Progress
4th Jul 202312:38 pmRNSIssue of Equity & TVR
29th Jun 20237:00 amRNSReese Ridge Project Update
12th Jun 20237:00 amRNSPioche Project Update
8th Jun 202312:16 pmRNSDIRECTOR DEALING, ISSUE OF EQUITY & TVR
5th Jun 20237:00 amRNSAdditional £200,000 Investment
31st May 202311:46 amRNSHalf-year Report
23rd May 20237:00 amRNSNatural Pozzolan Association Symposium
4th May 20233:34 pmRNSTotal Voting Rights
26th Apr 20237:00 amRNSPioche Project Update
14th Apr 202311:52 amRNSHolding(s) in Company
6th Apr 202312:38 pmRNSIssue of Equity & TVR
24th Mar 20237:00 amRNSISSUE OF WARRANTS
15th Mar 20237:00 amRNSNEW MINING CLAIMS: REESE RIDGE PROJECT
17th Feb 202311:57 amRNSResult of AGM
17th Feb 20237:00 amRNSAGM Chairman’s Statement
17th Jan 20239:19 amRNSDIRECTOR DEALING, ISSUE OF EQUITY & TVR
9th Jan 20237:00 amRNSPioche claims update
22nd Dec 20227:00 amRNSAnnual Report and Notice of AGM
21st Dec 20227:00 amRNSTolsa maintain option to acquire Sepiolite Project
13th Dec 20229:23 amRNSAudited Results for the year to 30 September 2022
7th Dec 20221:54 pmRNSIssue of Convertible Security
30th Nov 20227:00 amRNS£480,000 Investment, Issue of Equity & TVR
22nd Nov 202211:55 amRNSHolding(s) in Company
25th Oct 20227:00 amRNSUpdate - Pioche Sepiolite Project
12th Oct 20227:00 amRNSBulk Sampling - Hazen Pozzolan Project, Nevada
2nd Sep 20227:00 amRNSUpdate - Pioche Sepiolite Project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.